Skip to Main Content

De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation

Conditions

Children's Health | Diseases of the Digestive System - Liver

What is the purpose of this trial?

The purpose of this study is to provide insights into the cause, development and effects of de novo autoimmune hepatitis so that prevention and treatment strategies can be developed in order to reduce post-liver transplant morbidity, the frequency of liver allograft loss and the need for re-transplantation.

  • Trial with
    Yale University School of Medicine
  • Start Date
    03/14/2013
  • End Date
    12/11/2018
Trial Image

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    03/07/2018
  • Study HIC
    #1302011561